Clincosm LogoSign in Get a demo

recurrent gastric cancer

Showing 1 - 21 of 21
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach, Intestinal Adenocarcinoma of the Stomach

Active, not recruiting
Has Results
  • Adenocarcinoma of the Gastroesophageal Junction
  • +12 more
  • copper Cu 64-DOTA-trastuzumab
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach Trial in

Terminated
Has Results
  • Adenocarcinoma of the Esophagus
  • +13 more
  • oblimersen sodium
  • +2 more
  • Bronx, New York
    Montefiore Medical Center
Jan 29, 2021

Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach, Intestinal Adenocarcinoma of the Stomach

Completed
Has Results
  • Adenocarcinoma of the Gastroesophageal Junction
  • +7 more
  • Bronx, New York
    Montefiore Medical Center
Jan 29, 2021

Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Gastric Cancer Trial in Canada, United

Completed
Has Results
  • Adenocarcinoma of the Gastroesophageal Junction
  • +6 more
  • Dalton, Georgia
  • +4 more
Jul 26, 2018

Recurrent Gastric Cancer, Stage IV Gastric Cancer Trial in Duarte (imatinib mesylate, laboratory biomarker analysis)

Completed
Has Results
  • Recurrent Gastric Cancer
  • Stage IV Gastric Cancer
  • imatinib mesylate
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope
Jun 15, 2018

Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach Trial in

Completed
Has Results
  • Adenocarcinoma of the Esophagus
  • +8 more
  • Duarte, California
  • +2 more
Apr 26, 2017

Recurrent Gastric Cancer Trial in Singapore (TS-1 with cisplatin, TS-1 with oxaliplatin)

Unknown status
  • Recurrent Gastric Cancer
  • TS-1 with cisplatin
  • TS-1 with oxaliplatin
  • Singapore, Singapore
    National University Hospital
Jun 21, 2016

Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Gastric Cancer Trial in United States

Completed
Has Results
  • Adenocarcinoma of the Gastroesophageal Junction
  • +6 more
  • Sacramento, California
  • +29 more
Dec 16, 2015

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Advanced Adult Primary Liver Cancer Trial in Nashville (cetuximab,

Completed
  • Adenocarcinoma of the Colon
  • +66 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Sep 28, 2015

Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach, Intestinal Adenocarcinoma of the Stomach

Completed
Has Results
  • Adenocarcinoma of the Gastroesophageal Junction
  • +8 more
  • Cleveland, Ohio
    Case Western Reserve University
Apr 15, 2015

Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach, Intestinal Adenocarcinoma of the Stomach

Completed
Has Results
  • Adenocarcinoma of the Gastroesophageal Junction
  • +8 more
  • Duarte, California
  • +4 more
May 9, 2014

Adenocarcinoma of the Pancreas, Adenocarcinoma of the Stomach, BRCA1 Mutation Carrier Trial in Madison (veliparib, capecitabine,

Terminated
  • Adenocarcinoma of the Pancreas
  • +25 more
  • Madison, Wisconsin
    University of Wisconsin Hospital and Clinics
Apr 1, 2014

Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix, Estrogen Receptor-negative Breast Cancer Trial in

Completed
  • Advanced Adult Primary Liver Cancer
  • +87 more
  • Charlottesville, Virginia
    University of Virginia
Sep 27, 2013

Adenocarcinoma of the Gastroesophageal Junction, HER2-positive Breast Cancer, Male Breast Cancer Trial in New York (drug,

Terminated
  • Adenocarcinoma of the Gastroesophageal Junction
  • +11 more
  • Akt inhibitor MK2206
  • +3 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Sep 27, 2013

Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach, Intestinal Adenocarcinoma of the Stomach

Completed
  • Adenocarcinoma of the Gastroesophageal Junction
  • +8 more
  • irinotecan hydrochloride
  • +4 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 3, 2013

Male Breast Cancer, Recurrent Breast Cancer, Recurrent Endometrial Carcinoma Trial in Columbus (trastuzumab, paclitaxel,

Completed
  • Male Breast Cancer
  • +6 more
  • trastuzumab
  • +2 more
  • Columbus, Ohio
    Ohio State University Medical Center
Jun 3, 2013

Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases Trial in Columbus (recombinant interleukin-12,

Completed
  • Advanced Adult Primary Liver Cancer
  • +126 more
  • recombinant interleukin-12
  • ABI-007/carboplatin/trastuzumab
  • Columbus, Ohio
    Ohio State University Medical Center
Feb 27, 2013

Adenocarcinoma of the Colon, Adenocarcinoma of the Gallbladder, Adenocarcinoma of the Pancreas Trial in Philadelphia

Completed
  • Adenocarcinoma of the Colon
  • +41 more
  • recombinant fowlpox-CEA(6D)/TRICOM vaccine
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jan 24, 2013

Diffuse Adenocarcinoma of the Stomach, Intestinal Adenocarcinoma of the Stomach, Mixed Adenocarcinoma of the Stomach Trial in

Completed
  • Diffuse Adenocarcinoma of the Stomach
  • +5 more
  • lapatinib ditosylate
  • laboratory biomarker analysis
  • San Antonio, Texas
    Southwest Oncology Group
Jan 16, 2013

Advanced Adult Primary Liver Cancer, Carcinoma of the Appendix, Fallopian Tube Cancer Trial in Philadelphia (EF5, motexafin

Terminated
  • Advanced Adult Primary Liver Cancer
  • +70 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
Jan 15, 2013

Advanced Metastatic Gastric Cancer, Recurrent Gastric Cancer Trial in Goyang, Seoul (Paclitaxel)

Unknown status
  • Advanced Metastatic Gastric Cancer
  • Recurrent Gastric Cancer
  • Goyang, Korea, Republic of
  • +1 more
Dec 11, 2011